Exploring new and existing treatments for Alzheimer's disease in diverse communities
Official title: Use and Impact of Novel and Repurposed Therapeutics for Alzheimer's Disease and Related Dementia in Diverse Populations
Funded at University of Southern California · NIH-11309206 · Data updated 2026-11-12
This study is looking at new and existing medications for Alzheimer's disease, especially for non-Hispanic Black communities who may have a harder time getting these treatments, and it aims to understand the challenges they face so that everyone can have fair access to effective care.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Southern California NIH-funded |
| Lab location | 1 site (Los Angeles, UNITED STATES) |
| Project start | April 15, 2023 |
| Project end | March 31, 2028 |
| Funding year | 2025 |
| Award (this year) | $546,527 |
| NIH project number | 4R33AG081811-03 |
| Project ID | NIH-11309206 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include non-Hispanic Black individuals at risk for or diagnosed with Alzheimer's disease or related dementias.
✕Less likely to help
Patients who are not part of the non-Hispanic Black community or those without a risk of Alzheimer's disease or related dementias may not benefit from this research.
What this research studies
This research investigates the use of both novel and repurposed medications for Alzheimer's disease and related dementias, particularly focusing on non-Hispanic Black communities who are at higher risk. The study aims to understand the barriers these communities face in accessing these treatments, including issues related to trust in the medical system and structural racism. By engaging with community stakeholders, the research will gather qualitative and quantitative data to identify demand and access challenges for these therapeutics. The ultimate goal is to facilitate equitable access to effective treatments for Alzheimer's disease and related dementias.
Why it matters
Potential benefit: If successful, this research could lead to improved access to effective Alzheimer's treatments for underserved populations, potentially reducing the burden of the disease.
How similar studies have gone: Previous research has shown that addressing access barriers in underserved communities can lead to improved health outcomes, indicating that this approach has potential for success.
Where this research is happening
-
University of Southern California
Los Angeles, United States Active
Researchers
- Principal investigator: Zissimopoulos, Julie M — University of Southern California
- Study coordinator: Zissimopoulos, Julie M
Related research
Other NIH-funded projects on the same topics.
-
Global picture of dementia risk and memory loss across the world
A large international effort gathers data from many studies to understand how dementia and memory problems develop around the world, using shared information to reveal patterns and risk factors.
-
Automated language analysis for Alzheimer’s disease and frontotemporal dementia in Latino and English speakers
A low-cost, automated speech and language analysis tool is being developed to help identify Alzheimer’s disease or frontotemporal dementia in Latino and English-speaking people.
-
Automated language analysis for Alzheimer’s and frontotemporal dementia across Latino and English-speaking groups
A low-cost, automated language study aims to help diagnose and understand Alzheimer’s and FTD in diverse Spanish- and English-speaking communities.
-
Automated language analysis to help diagnose Alzheimer’s and frontotemporal dementia in Latino and English speakers
A low-cost, computer-based method analyzes speech and language to help identify Alzheimer’s disease or frontotemporal dementia in Latino and English-speaking people.
-
Automated language analysis for Alzheimer's and frontotemporal dementia in Latino and English-speaking communities
A low-cost, computer-based language analysis method is being developed to help identify Alzheimer’s disease and frontotemporal dementia in Latino and English-speaking people.
-
Automated language analysis to detect Alzheimer’s and frontotemporal dementia in Latino and English-speaking adults
A low-cost, computer-based language and speech analysis tool will help identify Alzheimer’s disease and frontotemporal dementia in Latino and English-speaking adults.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.